Anti-PSGL1 / CD162 Reference Antibody (neihulizumab)
Recombinant Antibody
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application ![]()
| FC, E, FTA |
---|---|
Primary Accession | Q14242 |
Reactivity | Human, Mouse |
Clonality | Monoclonal |
Isotype | IgG4 |
Calculated MW | 145.72 KDa |
Target/Specificity | PSGL1 / CD162 |
---|---|
Endotoxin | < 0.001EU/ µg,determined by LAL method. |
Conjugation | Unconjugated |
Expression system | CHO Cell |
Format | Purified monoclonal antibody supplied in PBS, pH6.0, without preservative.This antibody is purified through a protein A column. |
Name | SELPLG |
---|---|
Function | A SLe(x)-type proteoglycan, which through high affinity, calcium-dependent interactions with E-, P- and L-selectins, mediates rapid rolling of leukocytes over vascular surfaces during the initial steps in inflammation. Critical for the initial leukocyte capture. |
Cellular Location | Membrane; Single-pass type I membrane protein. |
Tissue Location | Expressed on neutrophils, monocytes and most lymphocytes |

If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.